73 related articles for article (PubMed ID: 828522)
1. Distribution of tetrahydrouridine in experimental animals.
el-Dareer SM; White V; Chen FP; Mellett LB; Hill DL
Cancer Treat Rep; 1976 Nov; 60(11):1627-31. PubMed ID: 828522
[TBL] [Abstract][Full Text] [Related]
2. Distribution and metabolism of vincristine in mice, rats, dogs, and monkeys.
El Dareer SM; White VM; Chen FP; Mellet LB; Hill DL
Cancer Treat Rep; 1977 Oct; 61(7):1269-77. PubMed ID: 412588
[TBL] [Abstract][Full Text] [Related]
3. Distribution of [3H]cytosine arabinoside and its products in mice, dogs, and monkeys and effect of tetrahydrouridine.
Dareer SM; Mulligan LT; White V; Tillery K; Mellett LB; Hill DL
Cancer Treat Rep; 1977; 61(3):395-407. PubMed ID: 406044
[No Abstract] [Full Text] [Related]
4. Distribution and metabolism of prednisone in mice, dogs, and monkeys.
El Dareer SM; Struck RF; White VM; Mellett LB; Hill DL
Cancer Treat Rep; 1977 Oct; 61(7):1279-89. PubMed ID: 412589
[TBL] [Abstract][Full Text] [Related]
5. Tetrahydrouridine: Physiologic disposition and effect upon deamination of cytosine arabinoside in man.
Kreis W; Woodcock TM; Gordon CS; Krakoff IH
Cancer Treat Rep; 1977 Oct; 61(7):1347-53. PubMed ID: 589600
[TBL] [Abstract][Full Text] [Related]
6. Disposition of 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-phosphate in mice and dogs.
Noker PE; Duncan GF; El Dareer SM; Hill DL
Cancer Treat Rep; 1983 May; 67(5):445-56. PubMed ID: 6189605
[TBL] [Abstract][Full Text] [Related]
7. Disposition of 9-beta-D-arabinofuranosyl-2-fluoroadenine in mice, dogs, and monkeys.
El Dareer SM; Struck RF; Tillery KF; Rose LM; Brockman RW; Montgomery JA; Hill DL
Drug Metab Dispos; 1980; 8(2):60-3. PubMed ID: 6103788
[TBL] [Abstract][Full Text] [Related]
8. Pharmacology of combination chemotherapy of cytosine arabinoside (ara-C) and uracil arabinoside (ara-U) or tetrahydrouridine (THU) against murine leukemia L1210/0 in tumor-bearing mice.
Avramis VI; Powell W
Cancer Invest; 1987; 5(4):293-9. PubMed ID: 3664332
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic considerations in evaluating the effects of tetrahydrouridine on 5-azacytidine chemotherapy in L1210 leukemic mice.
Kelly CJ; Gaudio L; Yesair DW; Schoenemann PT; Wodinsky I
Cancer Treat Rep; 1978 Jul; 62(7):1025-32. PubMed ID: 80268
[TBL] [Abstract][Full Text] [Related]
10. Pharmacology of a new triazine antifolate in mice, rats, dogs, and monkeys.
Cashmore AR; Skeel RT; Makulu DR; Gralla EJ; Bertino JR
Cancer Res; 1975 Jan; 35(1):17-22. PubMed ID: 803254
[TBL] [Abstract][Full Text] [Related]
11. Disposition of 5-methyltetrahydrohomofolate in mice, dogs, and monkeys.
El Dareer SM; Tillery KF; Hill DL
Cancer Treat Rep; 1979 Feb; 63(2):201-7. PubMed ID: 109197
[TBL] [Abstract][Full Text] [Related]
12. Distribution and elimination of melphalan in rats and monkeys and distribution in tumors of mice bearing L1210 or P388 leukemias sensitive and resistant to this agent.
Brown RK; Duncan G; Hill DL
Cancer Treat Rep; 1980; 64(4-5):643-8. PubMed ID: 6775804
[TBL] [Abstract][Full Text] [Related]
13. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of deamination of 14C-cytosine arabinoside (NSC-63878): a useful biologic assay for tetrahydrouridine (NSC-112907).
Furner RL; Mellett LB
Cancer Chemother Rep; 1975; 59(4):717-20. PubMed ID: 809135
[TBL] [Abstract][Full Text] [Related]
15. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 4th communication: absorption, metabolism, excretion and plasma protein binding in various animals and man.
Mizojiri K; Okabe H; Sugeno K; Misaki A; Ito M; Kominami G; Esumi Y; Takaichi M; Harada T; Seki H; Inaba A
Arzneimittelforschung; 1997 Mar; 47(3):259-69. PubMed ID: 9105544
[TBL] [Abstract][Full Text] [Related]
16. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
17. Studies on the comparative distribution and biliary excretion of doxorubicin and 4'-epi-doxorubicin in mice and rats.
Broggini M; Colombo T; Martini A; Donelli MG
Cancer Treat Rep; 1980; 64(8-9):897-904. PubMed ID: 6934850
[TBL] [Abstract][Full Text] [Related]
18. Distribution of clomesone in mice.
Noker PE; Hill DL
Cancer Treat Rep; 1987 Dec; 71(12):1135-40. PubMed ID: 2825990
[TBL] [Abstract][Full Text] [Related]
19. Disposition of the novel anticancer agent vinorelbine ditartrate following intravenous administration in mice, rats and dogs.
Kobayashi S; Sakai T; Dalrymple PD; Wood SG; Chasseaud LF
Arzneimittelforschung; 1993 Dec; 43(12):1367-77. PubMed ID: 8141830
[TBL] [Abstract][Full Text] [Related]
20. Tumor-selective metabolism of 5-fluoro-2'-deoxycytidine coadministered with tetrahydrouridine compared to 5-fluorouracil in mice bearing Lewis lung carcinoma.
Boothman DA; Briggle TV; Greer S
Cancer Res; 1987 May; 47(9):2354-62. PubMed ID: 2952263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]